Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
54
GATO Quote, Financials, Valuation and Earnings
Last price:
$13.86
Seasonality move
:
12.71%
Day range:
$13.79 - $14.39
52-week range:
$5.42 - $20.31
Dividend yield:
0%
P/E ratio:
28.79x
P/S ratio:
--
P/B ratio:
2.45x
Volume:
1.2M
Avg. volume:
830K
1-year change:
110.99%
Market cap:
$960.1M
Revenue:
--
EPS (TTM):
$0.48
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $34K | $30K | $89K | $180K | $79K | |
| Gross Profit | -$34K | -$30K | -$89K | -$180K | -$79K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.9M | $7.8M | $21.4M | $25.5M | $25.7M | |
| Other Inc / (Exp) | -$24.1M | -$17.6M | -$42.3M | $42.1M | $38.1M | |
| Operating Expenses | $3.8M | $8.6M | $23.1M | $25.6M | $25.7M | |
| Operating Income | -$3.9M | -$8.6M | -$23.2M | -$25.8M | -$25.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$30.9M | -$35M | -$65.9M | $16.1M | $13M | |
| Earnings of Discontinued Ops. | -$6.9M | -$5.4M | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $1.6M | $114K | |
| Net Income to Company | -$30.9M | -$35M | -$65.9M | $72.2M | $53.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$37.8M | -$40.4M | -$65.9M | $14.5M | $12.9M | |
| Basic EPS (Cont. Ops) | -$0.67 | -$0.93 | -$1.03 | $0.21 | $0.19 | |
| Diluted EPS (Cont. Ops) | -$0.67 | -$0.93 | -$1.03 | $0.21 | $0.18 | |
| Weighted Average Basic Share | $56.1M | $43.7M | $64M | $69.2M | $69.2M | |
| Weighted Average Diluted Share | $56.1M | $43.7M | $64M | $69.3M | $69.5M | |
| EBITDA | -$30.9M | -$31M | -$65.6M | $85.9M | $88.8M | |
| EBIT | -$30.9M | -$31M | -$65.7M | $16.5M | $13.7M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$3.9M | -$8.6M | -$23.2M | -$25.8M | -$25.8M | |
| Operating Income (Adjusted) | -$30.9M | -$31M | -$65.7M | $16.5M | $13.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $7K | $31K | $44K | $3K | $4K | |
| Gross Profit | -$7K | -$31K | -$44K | -$3K | -$4K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2M | $7.2M | $5.9M | $7.5M | $10.4M | |
| Other Inc / (Exp) | $2.5M | -$7.2M | $10M | $10.7M | $19.7M | |
| Operating Expenses | $2.1M | $7.7M | $5.9M | $7.5M | $10.6M | |
| Operating Income | -$2.1M | -$7.8M | -$6M | -$7.5M | -$10.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $433K | -$15M | $4M | $3.3M | $10.4M | |
| Earnings of Discontinued Ops. | -$1.6M | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $525K | -- | $529K | |
| Net Income to Company | $433K | -$15M | $3.5M | $3.3M | $9.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.2M | -$15M | $3.5M | $3.3M | $9.9M | |
| Basic EPS (Cont. Ops) | -$0.02 | -$0.22 | $0.05 | $0.05 | $0.14 | |
| Diluted EPS (Cont. Ops) | -$0.02 | -$0.22 | $0.05 | $0.05 | $0.14 | |
| Weighted Average Basic Share | $53.9M | $67.1M | $69.2M | $69.2M | $69.3M | |
| Weighted Average Diluted Share | $53.9M | $67.1M | $69.3M | $69.5M | $71.6M | |
| EBITDA | $440K | -$7.7M | -$5.9M | $3.6M | $10.4M | |
| EBIT | $433K | -$7.8M | -$6M | $3.6M | $10.4M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$2.1M | -$7.8M | -$6M | -$7.5M | -$10.6M | |
| Operating Income (Adjusted) | $433K | -$7.8M | -$6M | $3.6M | $10.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -$1.9M | $51K | $176K | $122K | $16K | |
| Gross Profit | $1.9M | -$51K | -$176K | -$122K | -$16K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2M | $21.2M | $20.7M | $27.7M | $31.8M | |
| Other Inc / (Exp) | -$30.5M | $20.3M | -$30.5M | $34.1M | $62.9M | |
| Operating Expenses | $2.5M | $22.8M | $21M | $27.7M | $32M | |
| Operating Income | -$668K | -$22.9M | -$21.2M | -$27.8M | -$32M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$34.2M | -$11.9M | -$52.1M | $6M | $34.7M | |
| Earnings of Discontinued Ops. | -$4.9M | -$471K | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $700K | $815K | |
| Net Income to Company | -- | -$11.9M | -$52.9M | $63M | $74.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$46.1M | -$12.4M | -$52.9M | $5.3M | $33.9M | |
| Basic EPS (Cont. Ops) | -$0.83 | -$0.18 | -$0.83 | $0.08 | $0.49 | |
| Diluted EPS (Cont. Ops) | -$0.83 | -$0.18 | -$0.83 | $0.08 | $0.48 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$10.3M | -$23.9M | -$63.5M | $104.3M | $109.8M | |
| EBIT | -$10.4M | -$24M | -$63.7M | $34.9M | $34.7M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$668K | -$22.9M | -$21.2M | -$27.8M | -$32M | |
| Operating Income (Adjusted) | -$10.4M | -$24M | -$63.7M | $34.9M | $34.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $24K | $45K | $132K | $74K | $11K | |
| Gross Profit | -$24K | -$45K | -$132K | -$74K | -$11K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.3M | $17.8M | $17M | $19.2M | $25.3M | |
| Other Inc / (Exp) | -$19.7M | $16.6M | $27.9M | $19.8M | $44.6M | |
| Operating Expenses | $4.9M | $19.2M | $17.1M | $19.2M | $25.5M | |
| Operating Income | -$4.9M | -$19.2M | -$17.2M | -$19.3M | -$25.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$26.2M | -$3.1M | $10.7M | $530K | $22.3M | |
| Earnings of Discontinued Ops. | -$4.9M | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $865K | -- | $701K | |
| Net Income to Company | -$26.2M | -$3.1M | $9.8M | $530K | $21.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$31.2M | -$3.1M | $9.8M | $530K | $21.6M | |
| Basic EPS (Cont. Ops) | -$0.56 | -$0.02 | $0.15 | $0.01 | $0.31 | |
| Diluted EPS (Cont. Ops) | -$0.56 | -$0.02 | $0.15 | $0.01 | $0.31 | |
| Weighted Average Basic Share | $164M | $186M | $207.5M | $207.5M | $207.7M | |
| Weighted Average Diluted Share | $164M | $187.1M | $207.8M | $208M | $213.1M | |
| EBITDA | -$2.3M | -$19.2M | -$17.1M | $1.3M | $22.3M | |
| EBIT | -$2.3M | -$19.2M | -$17.2M | $1.2M | $22.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$4.9M | -$19.2M | -$17.2M | -$19.3M | -$25.5M | |
| Operating Income (Adjusted) | -$2.3M | -$19.2M | -$17.2M | $1.2M | $22.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.6M | $150.1M | $6.6M | $17M | $55.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $188K | $3.6M | $3M | $2.9M | $1.9M | |
| Other Current Assets | -- | $1K | $7K | $151K | $37K | |
| Total Current Assets | $18.5M | $155.8M | $11.8M | $35.6M | $78.7M | |
| Property Plant And Equipment | $92K | -- | -- | -- | -- | |
| Long-Term Investments | $105.4M | $109.6M | $333.4M | $347.8M | $321.9M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $30.4M | $61K | $35K | $60K | $38K | |
| Total Assets | $154.3M | $265.4M | $345.2M | $383.5M | $400.9M | |
| Accounts Payable | $60K | $560K | $196K | $586K | $2.7M | |
| Accrued Expenses | $1.5M | $1.2M | $623K | $2.8M | $3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $648K | $260K | -- | $122K | $11K | |
| Total Current Liabilities | $3.5M | $4M | $1.4M | $26.4M | $33.4M | |
| Long-Term Debt | -- | -- | $12.6M | $8.7M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.9M | $4M | $14M | $35M | $33.4M | |
| Common Stock | $80K | $108K | $117K | $117K | $117K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $149.4M | $261.4M | $331.2M | $348.5M | $367.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $149.4M | $261.4M | $331.2M | $348.5M | $367.5M | |
| Total Liabilities and Equity | $154.3M | $265.4M | $345.2M | $383.5M | $400.9M | |
| Cash and Short Terms | $8.6M | $150.1M | $6.6M | $17M | $55.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.6M | $12.4M | $15.3M | $33.5M | $116.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $106K | -- | -- | -- | -- | |
| Prepaid Expenses | $383K | -- | $387K | $816K | $558K | |
| Other Current Assets | -- | $1.1M | $7K | $93K | $10K | |
| Total Current Assets | $9M | $14.7M | $16.9M | $50.5M | $118.2M | |
| Property Plant And Equipment | $28.4M | -- | -- | -- | -- | |
| Long-Term Investments | $105.2M | $393.6M | $371.5M | $328.7M | $285.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $250K | $41K | $39K | $42K | $348K | |
| Total Assets | $142.8M | $408.4M | $388.4M | $379.3M | $404.3M | |
| Accounts Payable | $183K | $263K | $887K | $1.1M | $2.7M | |
| Accrued Expenses | $2.5M | $955K | $361K | $2.4M | $6.4M | |
| Current Portion Of Long-Term Debt | $15.6M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $39K | -- | |
| Other Current Liabilities | -- | $260K | -- | -- | $132K | |
| Total Current Liabilities | $19.8M | $4M | $2.3M | $26.4M | $12.2M | |
| Long-Term Debt | -- | $12.6M | $12.7M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $21.3M | $16.6M | $15.1M | $26.4M | $12.4M | |
| Common Stock | $80K | $117K | $117K | $117K | $117K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $121.5M | $391.8M | $373.4M | $352.9M | $391.9M | |
| Total Liabilities and Equity | $142.8M | $408.4M | $388.4M | $379.3M | $404.3M | |
| Cash and Short Terms | $3.6M | $12.4M | $15.3M | $33.5M | $116.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$30.9M | -$35M | -$65.9M | $72.2M | $53.4M | |
| Depreciation & Amoritzation | $34K | $30K | $89K | $69.4M | $75.1M | |
| Stock-Based Compensation | $3M | $4.4M | $7.7M | -- | -- | |
| Change in Accounts Receivable | -$5.1M | -$4.8M | $134K | -$18.4M | $34.4M | |
| Change in Inventories | -- | -- | -- | -$353K | -$5.3M | |
| Cash From Operations | -$12.3M | -$18.4M | -$21.5M | $157.4M | $142M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$21.4M | -$12.3M | -$261.4M | -- | -- | |
| Cash From Investing | -$21.9M | -$12.1M | -$261.4M | -$82.3M | -$57.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$55M | -$85M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $15M | $13M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$5.4M | -$547K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$637K | -$3.8M | -$7.7M | -- | -- | |
| Cash From Financing | $39.8M | $172.5M | $139.4M | -$60.4M | -$85.5M | |
| Beginning Cash (CF) | $3.5M | $9.1M | $150.1M | $20.3M | $34.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $5.6M | $141.9M | -$143.5M | $14.7M | -$633K | |
| Ending Cash (CF) | $8.6M | $150.1M | $6.6M | $34.9M | $34.3M | |
| Levered Free Cash Flow | -$12.3M | -$18.4M | -$21.5M | $75.4M | $85.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $433K | -$15M | $3.5M | $3.3M | $9.9M | |
| Depreciation & Amoritzation | $7K | $31K | $44K | $3K | $4K | |
| Stock-Based Compensation | $1M | $2.3M | $739K | $2.1M | $1M | |
| Change in Accounts Receivable | -$455K | $3.8M | -$10K | $1.1M | -$137K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.4M | -$7.6M | $8M | $33.3M | $34.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$810K | -$144.8M | -- | -- | -- | |
| Cash From Investing | -$832K | -$144.8M | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $5M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$9M | -$35K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$134K | -$7.4M | -- | -- | -- | |
| Cash From Financing | $4.9M | $135.2M | -- | -$9M | $20K | |
| Beginning Cash (CF) | $1.6M | $29.6M | $7.3M | $9.1M | $82.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.7M | -$17.2M | $8M | $24.3M | $34.3M | |
| Ending Cash (CF) | $3M | $12.4M | $15.3M | $33.5M | $116.7M | |
| Levered Free Cash Flow | -$2.4M | -$7.6M | $8M | $33.3M | $34.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$11.9M | -$52.9M | $63M | $74.5M | |
| Depreciation & Amoritzation | -- | $51K | $176K | $69.3M | $75M | |
| Stock-Based Compensation | $3M | $7.1M | $4.1M | $1.2M | $992K | |
| Change in Accounts Receivable | -- | -$518K | $694K | -$18.8M | $34M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$22M | $2.7M | $174.2M | $177.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$8.4M | -$265.4M | -- | -- | -- | |
| Cash From Investing | -- | -$265.2M | -$27K | -$82.3M | -$57.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$14.4M | $8.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$11M | -- | -- | -- | |
| Cash From Financing | -- | $296.8M | $209K | -$69.4M | -$76.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $9.7M | $2.9M | $22.5M | $44.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$22M | $2.7M | $174.2M | $177.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$26.2M | -$3.1M | $9.8M | $530K | $21.6M | |
| Depreciation & Amoritzation | $24K | $45K | $132K | $74K | $11K | |
| Stock-Based Compensation | $3M | $5.8M | $2.1M | $3.3M | $4.3M | |
| Change in Accounts Receivable | -$3.8M | $446K | $1M | $678K | $268K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$11.9M | -$15.5M | $8.7M | $25.5M | $61.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$8.4M | -$261.4M | -- | -- | -- | |
| Cash From Investing | -$8.4M | -$261.4M | -$27K | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $15M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$9M | -$89K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$462K | -$7.7M | -- | -- | -- | |
| Cash From Financing | $14.8M | $139.2M | -- | -$9M | $77K | |
| Beginning Cash (CF) | $11.9M | $210.8M | $19.2M | $39M | $208.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$5.5M | -$137.7M | $8.7M | $16.5M | $61.2M | |
| Ending Cash (CF) | $5.8M | $73M | $27.8M | $55.5M | $269.8M | |
| Levered Free Cash Flow | -$11.9M | -$15.5M | $8.7M | $25.5M | $61.2M | |
Get GATO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GATO
Sector
P/E ratio
28.79x
15.81x
PEG ratio
--
0.00x
P/B ratio
2.45x
1.20x
Price / LTM sales
--
1.40x
Growth Metrics
GATO
Sector
Revenue growth
--
0.55%
Earnings growth
180%
-0.16%
Revenue (5-year growth)
--
3.85%
Earnings forecast
$0.13
$0.06
Profitability
GATO
Sector
Profitability FY 2023
-$79K
$261.6K
Return on invested capital
--
2.13%
Return on assets
--
1.47%
Return on equity
--
3.08%
Earnings Date
Last Earnings Date
Nov
11
Next Earnings Date
Feb
20
Estimated Next Earnings Date
Feb
10
Balance Sheet
GATO
Sector
Total cash
$116.7M
$3.1M
Short term investments
--
$460.5K
Total assets
$400.9M
$27.1M
Long term debt
--
$49.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
